These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7872726)

  • 1. Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(6B):2831-4. PubMed ID: 7872726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial hyperplasia. Clinico-pathological considerations of a prospective randomised study after abrasio only or high-dose gestagen treatment. Results of 2 years follow-up of 292 patients.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(1):403-6. PubMed ID: 1826823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
    Lindahl B; Alm P; Fernö M; Norgren A
    Anticancer Res; 1990; 10(3):725-30. PubMed ID: 2142394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.
    Ørbo A; Arnes M; Hancke C; Vereide AB; Pettersen I; Larsen K
    Gynecol Oncol; 2008 Oct; 111(1):68-73. PubMed ID: 18684496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
    Vereide AB; Kaino T; Sager G; Ørbo A;
    Gynecol Oncol; 2005 Jun; 97(3):740-50. PubMed ID: 15885761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
    Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
    Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follow-up study after withdrawal of estrogens.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(6):2071-3. PubMed ID: 1776842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Operative treatment of endometrial hyperplasia in kidney graft recipients: report of seven cases.
    Bobrowska K; Pietrzak B; Jabiry-Zieniewicz Z; Cyganek A; Kaminski P; Wielgos M; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2756-8. PubMed ID: 18021979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial abnormalities in infertile women.
    Kurabayashi T; Kase H; Suzuki M; Sugaya S; Fujita K; Tanaka K
    J Reprod Med; 2003 Jun; 48(6):455-9. PubMed ID: 12856518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
    Mittal K; Da Costa D
    Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous endometrial hyperplasia. The prognostic significance of steroid receptor concentration. A two year follow-up of patients treated with abrasio only.
    Lindahl B; Fernö M; Norgren A; Willen R
    Anticancer Res; 1991; 11(5):1875-7. PubMed ID: 1768058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation.
    Yasuda M; Matsui N; Kajiwara H; Osamura RY; Miyamoto T; Murakami M; Shinozuka T; Itoh J
    Pathol Int; 2004 Jun; 54(6):451-6. PubMed ID: 15144406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
    Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
    Lindahl B; Willén R
    Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical endometrial hyperplasia. Prognosis and course].
    Jensen HH; Hussain SF; Pedersen PH; Andreasson B
    Ugeskr Laeger; 2000 Jan; 162(5):666-9. PubMed ID: 10707601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up.
    Pérez-Medina T; Bajo J; Folgueira G; Haya J; Ortega P
    Gynecol Oncol; 1999 May; 73(2):299-304. PubMed ID: 10329050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.